Erythrocyte sedimentation rate control
US5888822A · kind A · utility
13Cited by
19References
36Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 4, 1995 |
| Grant date | Mar 30, 1999 |
| Priority date | — |
| Expiry date | Oct 4, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/106664
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A three-phase suspension suitable for use as an erythrocyte sedimentation rate control having the following three components: (1) a synthetic plasma base, (2) a high molecular weight polymer, and (3) mammalian red blood cells. The control is designed to allow the user to monitor the accuracy and precision of analytical methods for determining the sedimentation rate of human erythrocytes in whole blood specimens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.